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A B S T R A C T
The elevated I-maze is a modification of the elevated plus-maze model of anxiety in mice.
The design of I-maze comprises a straight wooden passage, resembling the English letter
“I,” divided equally into three areas; two enclosed areas (close arms) at both ends of the
“maze” and an open area in the center of two enclosed areas. The I-maze completely avoids
the central platform of elevated plus-maze, removing any ambiguity in time spent on central
platform and allowing uninterrupted animal exploration. In this model, diazepam (1 mg/kg)
and gabapentin (10 mg/kg) significantly increased the percentage of time spent in the open
areas (%TO) and the number of unprotected head dips (uHDIPS), and reduced the number
of protected head dips (pHDIPS) and stretch attend postures (SAP) from close to open arm.
Similarly, fluoxetine (5 mg/kg) significantly increased %TO and uHDIPS, and significantly de-
creased SAP from close to open arm, but it did not have any significant effect on pHDIPS.
The 5-HT3 receptor antagonist, ondansetron (0.1 mg/kg), did not produce any significant change
in all the behaviors, observed, as compared to vehicle-treated control mice. On the other
hand, the anxiogenic agent, caffeine (15 mg/kg), did produce a significant decrease in %TO
and uHDIPS, and significantly increased pHDIPS and SAP from close to open arm. Mice con-
fined in open area of I-maze bring the relevant biochemical changes associated with anxiety
behavior, showing significant increase in the levels of plasma nitrate and plasma corticos-
terone. These data indicate that a combination of novel design of elevated I-maze and a
detailed behavioral analysis provides a sensitive model for the measurement of anxiety.
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Human anxiety is defined as a feeling of apprehension, un-
certainty and tension stemming from the anticipation of an
imagined or unreal threat (Ninan, 2001). Pharmacological evalu-
ation of anti-anxiety agents is done using different exclusively
designed behavioral paradigms. A model of anxiety is an ex-
perimental system or paradigm to simulate some aspects of
anxiety disorders in which the effects of anxiolytic drugs are
examined. Animal behavioral profiles such as locomotion, self
grooming, defecation and urination have long been used to
detect effects on anxiety, and a number of models, based on
animal emotional reactivity, have been proven to be sensitive
to stressful manipulations. Many of these models have been
successfully used to test new anxiolytic drugs by simple, rapid
and inexpensive ways of evaluating animals’ conditions. In this
class of tests environmental stimuli or contexts are used to
induce anxiety states in animals. Studies on antianxiety com-
pounds generally involve exposing the animal to a situation
that has not been experienced before, or after some time. Most
of them involve putting an animal into a novel enclosure such
as maze, open field or other test chamber.
Several experimental paradigms have been constructed to
test anxiety in the rodent (Belzung, 1999). In particular, the el-
evated plus-maze has been used and validated as a tool to assess
anxiety in rodents, as well as to determine the efficacy of various
anxiolytic compounds. In this paradigm, subjects are placed
on the central platform of the elevated plus-maze at the start
of the test, and the amount and distribution of time spent in
the open and closed arms are measured. Increased time spent
in the open arms is indicative of a low level of anxiety, whereas
increased time spent in the closed arms is indicative of a high
level of anxiety. Validation of this procedure has been con-
firmed by the effects of anxiolytic compounds. Earlier
modifications in the design of elevated plus-maze are (a) el-
evated Zero-maze (EZM) (Shepherd et al., 1992a, 1992b) and (b)
elevated T-maze (ETM) (Graeff et al., 1993). These mazes were
designed and proposed as animal models of anxiety, which lack
the inherent deficiency in the design of elevated plus-maze;
there exists an inherent limitation in the plus maze design, of
the unavoidable ambiguity, which is associated with time spent
on the central square of plus-maze. It is argued by various
workers that period spent on central platform compromises
interpretation of time spent in open/close arms. Further, mice
have been observed to spend 20–30% of the test period on central
square (Lee and Rodgers, 1990). The elevated T-maze was de-
signed to offer the provision of testing conditioned and
unconditioned fear in the single apparatus, whereas elevated
zero-maze was utilized for detailed behavioral analysis in-
cluding risk assessment by animal, in addition to measuring
anxiety. Though, these mazes offer clear advantages over el-
evated plus-maze viz. avoidance of central platform (in case
of both ETM and EZM) and uninterrupted exploration of the
apparatus (in case of EZM), the I-maze design facilitates (a) ex-
pedited exploration of the maze because, as the animal reaches
the end of the closed end, it spontaneously turns back and en-
counters a much clear view (option) of open space, present
inherently between two closed arms (choices), as compared to
all other mazes like EPM, ETM and EZM. (b) Authors opine that
I-maze offers a rather more robust measure of anxiety as com-
pared to the designs of EPM, ETM and EZM, because during the
whole period of animal stay (300 sec) in the maze, the design
of I-maze facilitates a clear view of all the portions of the maze.
Due to such structure of the maze, during its stay in any one
arm (open or close), the animal has always a clear vision of
other arm, where it can enter as per its own preference. This
feature adds to the reliability of the I-maze, because the animal
during its stay in open arm still has a clear view of close arms,
on both sides of its stay on the straight open platform of the
maze. In this situation, still, if the animal does not opt to enter
close arm, then it may be taken as a more robust measure of
animal preference for open arm i.e. anxiolytic-like behavior of
animal or drug action, rather than an artifact or an unex-
plained stay of animal in any one arm (out of animal’s own
confusion and retardation of decision making, which is an in-
herent feature of anxiety or due to lack of a clear view of another
arm during its stay in one arm). (c) This further adds to the
utility of I-maze to facilitate a significant interpretation of more
subtle drug effects. (d) Further, similar to ETM and EZM, I-maze
also avoids the central platform in its design.
Various categories of drugs, like benzodiazepines, barbitu-
rates, alcohol, tri-cyclic antidepressant, have been used for long
time to treat anxiety. Apart from these established categories
of drugs, there are certain categories, which have been ex-
plored for their anxiolytic potential. These include selective
serotonin reuptake inhibitors (SSRIs) like paroxetine, citalopram
and fluoxetine. These categories have been considered as pos-
sible therapeutic replacements for some of traditional anxiolytics
because they are found to have comparable anxiolytic effect to
diazepam. Further, some anti-epileptics like tiagabin, gabapentin
and pregabalin have been explored for anxiety treatment.
The present study was undertaken to examine the pos-
sible anti-anxiety activity of selected categories of drugs on a
proposed model of anxiety, named as “I-maze.” A model is said
to be behaviorally validated, if a model facilitates the expres-
sion of a significant pharmacological activity of selected drugs
in mice, thereby showing a clear behavioral change in mice,
as a result of administration of selected drug(s).
In the brain, NOS has been localized in regions involved with
anxiety, such as hypothalamus, amygdala and hippocampus
(Vincent, 1994). There is evidence suggesting the role of NO/
cGMP signaling pathway in effect of NO on anxiety (Eroglu and
Caglayan, 1997). Inhibition of nitric oxide–cGMP pathways by
inhibition of NOS has been reported to produce antianxiety effect
(Spolidório et al., 2007). Stressful events have been found to
enhance anxiety in rodents, and plasma corticosterone is re-
ported to be a hormonal marker of anxiety (Mitra and Sapolsky,
2008; Zhao et al., 2014). Therefore, in the present hypothesis,
if the present model facilitates the expression of a significant
change in plasma nitrite and plasma corticosterone in mice, it
will show the biochemical validation of animal model.
2. Materials and methods
2.1. Animals
Swiss albino mice (male; 20–25 g) were used in this study.
Animals were housed under standard laboratory conditions,
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maintained on a 12 hour light and dark cycle. Animals had free
access to standard food and water. Animals were acclima-
tized to laboratory conditions before the test.
2.2. Apparatus
The apparatus is a straight wooden passage, resembling the
English letter “I” (Fig. 1a). It consists of a 48 cm × 5 cm, straight
passage, divided equally (16 cm each) into two enclosed areas
(close arms) at both ends of the “maze” and an open area in
the center of two enclosed ends (arms). Height of the walls of
enclosed areas is 12 cm. Final dimensions of “I” maze are pro-
posed to be 48 cm long × 5 cm wide with 12 cm high walls at
both ends. The entire maze is elevated to the height of 25 cm
(Fig. 1b).
2.3. Plasma corticosterone estimation
The quantitative estimation of plasma corticosterone level was
performed by the method of Bartos and Pesez (1979).
2.4. Plasma nitrite estimation
For nitrite estimation, plasma was collected using cooling cen-
trifuge at 2500 rpm and 4 °C for 10 min. The plasma was stored
in a refrigerator for estimation of nitrite content within 24 h.
Plasma nitrite was measured by a spectrophotometric assay
based on the Griess reaction (Green et al., 1982).
2.5. Experimental protocol
Each experimental animal group consisted of ten mice each
(n = 10). For behavioral characterization, vehicle (distilled water)
(10 ml/kg, ip), diazepam (1 mg/kg, ip), Gabapentin (10 mg/kg,
ip), Fluoxetine (5 mg/kg, ip), Ondansetron (0.1 mg/kg, ip), caf-
feine (15 mg/kg, ip) were administered in separate groups of
mice, 30 min before subjecting them to behavioral testing. After
30 min of vehicle or drug treatments, animals were observed
for total 5 min duration with the help of a video tracking system,
and behaviors were analyzed and documented by a blind ob-
server from these recordings. In all experiments, i.e. before
placing each animal on the maze, the test apparatus (maze)
was cleaned with 5% ethanol and thoroughly dried between
each test period. All the experiments were carried out between
09:00 a.m. and 03:00 p.m. The experimental protocols were ap-
proved by institutional animal ethics committee and were
conducted as per CPCSEA guidelines on use and care of ex-
perimental animals. The following behavior parameters were
studied in the mice.
2.5.1. Percent time spent in open arm (% TO)
It denotes the time which is spent by animals in open area
(open arm). It is calculated as percentage time spent in open
arm. Animals were scored as in the open area, when all four
paws of animal were in an open arm (Fig. 2). It was deter-
mined as follows:
% Time spent
number of seconds spent on open arms
sec
= ×100
300 onds min observation time5( )
2.5.2. Unprotected head dips (uHDIPS)
It denotes scanning by animal over the sides of the maze down-
ward towards the floor from unprotected area i.e. uncovered
open arm. uHDIPS are counted as the number of head dips from
open arm (Fig. 3).
2.5.3. Head dipping from close arm (pHDIPS)
It denotes scanning by animal over the sides of the maze down-
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25 cm
Fig. 1 – (a) Top view of elevated I-Maze. (b) Scheme of I
maze, showing proposed dimensions.
Fig. 2 – Time spent in open arm (% TO).
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arm. pHDIPS are counted as the number of head dips from close
arm (Fig. 4).
2.5.4. Stretch attend posture (SAP)
It is characterized by a forward elongation of the body exhib-
ited when the animal is either standing still or moving slowly
forward (Fig. 5).
All the above mentioned behavioral patterns are helpful to
assess anxiety behavior in rodents, which has been shown by
mice behavior on elevated I maze.
For biochemical estimation, plasma nitrite and plasma cor-
ticosterone were made on samples collected from animals that
were confined to open arm of the maze for 20 min by placing
a wooden block at both entries of the closed arm and com-
pared with the vehicle treated mice.
2.6. Statistics
All the results are expressed as Mean ± S.E.M. The data were
analyzed by Student’s t-test. P < 0.05 was considered as sta-
tistically significant.
3. Results
In the present model, a significant increase in time spent by mice
on open arm (%TO) and unprotected head dips (uHDIPS) and a
significant decrease in protected head dips (pHDIPS) and
stretched attend postures (SAP) indicate an antianxiety-like be-
havior. On the other hand, a significant decrease in time spent
by mice on open arm (%TO) and unprotected head dips (uHDIPS)
and a significant increase in protected head dips (pHDIPS) and
stretched attend postures (SAP) indicate an anxiety-like behavior.
3.1. Effect of diazepam
Diazepam (1 mg/kg) produced a significant increase in %TO,
an increase in uHDIPS, a decrease in pHDIPS and a decrease
in SAP, as compared to that in vehicle-treated mice (Figs. 6–9).
All these data suggest that diazepam show an anxiolytic-like
activity on I-maze.
3.2. Effect of gabapentin
Gabapentin (10 mg/kg) produced a significant increase in %TO,
an increase in uHDIPS, a decrease in pHDIPS and a decrease
in SAP, as compared to that in vehicle-treated mice (Figs. 10–13).
All these data suggest that gabapentin shows an anxiolytic-
like activity on I-maze.
3.3. Effect of fluoxetine
Fluoxetine (5 mg/kg) produced a significant increase in %TO,
an increase in uHDIPS, a decrease in SAP but did not produced
Fig. 3 – Unprotected Head Dipping (uHDIP).
Fig. 4 – Protected Head Dipping (pHDIP).
Fig. 5 – Stretched Attend Posture (SAP).
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any change in pHDIPS as compared to that in vehicle-treated
control mice (Figs. 14–17). All these data suggest that fluoxetine
show an anxiolytic-like activity on I-maze.
3.4. Effect of ondansetron
Ondansetron (0.1 mg/kg) did not produce any significant change
in all the parameters, as compared to vehicle-treated control
group (Figs. 18–21).
3.5. Effect of caffeine
Caffeine (15 mg/kg) produced a significant decrease in %TO, a
significant decrease in uHDIPS, an increase in pHDIPS and an
increase in SAP, as compared to that in vehicle-treated mice
(Figs. 22–25). All these data suggest that caffeine show an
anxiogenic-like activity on I-maze.
Fig. 6 – Effect of diazepam on percent time spent by mice in
open arm (%TO). n = 10 in each group. Values are expressed
as mean ± S.E. Data were analyzed by Student t-test.
a = p < 0.05 significant difference from vehicle-treated
control group. Values mentioned are doses in mg/kg.
Fig. 7 – Effect of diazepam on number of unprotected head
dips (uHDIP) by mice. n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. a = p < 0.05 significant difference from vehicle-
treated control group. Values mentioned are doses in
mg/kg.
Fig. 8 – Effect of diazepam on number of protected head
dips (pHDIP) by mice. n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. a = p < 0.05 significant difference from vehicle-
treated control group. Values mentioned are doses in
mg/kg.
Fig. 9 – Effect of diazepam on number of Stretch Attend
Postures (SAP) by mice. n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. a = p < 0.05 significant difference from vehicle-
treated control group. Values mentioned are doses in
mg/kg.
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3.6. Plasma nitrite estimation
Plasma nitrite level was significantly increased in mice con-
fined in open arm as compared to vehicle treated mice (Fig. 26).
3.7. Plasma corticosterone estimation
Plasma corticosterone level was significantly increased in mice
confined in open arm as compared to vehicle treated mice
(Fig. 27).
4. Discussion
An experimental model of anxiety should be analogous to the
human disorder in symptoms. A model is required to produce
a behavioral change that (a) can be monitored, (b) should
respond to standard clinical treatments and (c) should exhibit
reproducibility in animal behavior (McKinney and Bunney, 1969).
An animal model should at least display three kinds of validity
Fig. 10 – Effect of gabapentin on percent time spent by mice
in open arm (%TO). n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. a = p < 0.05 significant difference from vehicle-
treated control group. Values mentioned are doses in
mg/kg.
Fig. 11 – Effect of gabapentin on number of unprotected
head dips (uHDIP) by mice. n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. a = p < 0.05 significant difference from vehicle-
treated control group. Values mentioned are doses in
mg/kg.
Fig. 12 – Effect of gabapentin on number of protected head
dips (pHDIP) by mice. n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. a = p < 0.05 significant difference from vehicle-
treated control group. Values mentioned are doses in
mg/kg.
Fig. 13 – Effect of gabapentin on number of Stretch Attend
Postures (SAP) by mice. n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. a = p < 0.05 significant difference from vehicle-
treated control group. Values mentioned are doses in
mg/kg.
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namely (a) face validity i.e. it should produce anxiety-like symp-
toms in animal, (b) construct validity i.e. its physical design
should produce similar biochemical changes as observed in
clinical anxiety and (c) predictive validity i.e. animal behav-
ior on the maze should respond to standard therapeutic
treatments (Geyer and Markou, 2000).The present maze studies
in the present paper bears a physical design that is helpful in
studying detailed anxiety-like behavioral changes. Further, “I-
maze” provides an environment, which helps to increase the
sensitivity to, and facilitating interpretation of drug action. The
novel apparatus does not possess central platform, as mice have
been observed to spent 20–30% time on central square of el-
evated plus maze (Lee and Rodgers, 1990). Removal of the
central area further helps to detect drug effects on time spent
in the open area (Shepherd et al., 1992a, 1992b). Design of I-maze
covers maximum relevant features of anxiety – (a) open and
close arms for exploration; (b) no central platform; (c) clear de-
marcation between open and closed areas, that (i) contrasts
the stretched attend postures (SAP) and (ii) provides clear dif-
ferentiation between protected (close) and unprotected (open)
environment to observe unprotected and protected head dips.
Therefore, I-maze offers feasibility of detailed behavioral analy-
sis by employing viz. (a) unprotected head dip, (b) protected
head dip and (c) stretch attend posture; the relevant features
of human anxiety. The behaviors that are considered as ex-
perimentally reliable behaviors for studying anxiety in rodents
are (a) time spent in open space, (b) number of head dips from
Fig. 14 – Effect of fluoxetine on percent time spent (%TO) by
mice in open arm. n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. a = p < 0.05 significant difference from vehicle-
treated control group. Values mentioned are doses in
mg/kg.
Fig. 15 – Effect of fluoxetine on unprotected head dips by
mice. n = 10 in each group. Values are expressed as
mean ± S.E. Data were analyzed by Student t-test.
a = p < 0.05 significant difference from vehicle-treated
control group. Values mentioned are doses in mg/kg.
Fig. 16 – Effect of fluoxetine on protected head dips by
mice. n = 10 in each group. Values are expressed as
mean ± S.E. Data were analyzed by Student t-test. Values
mentioned are doses in mg/kg.
Fig. 17 – Effect of fluoxetine on stretch attend postures
(SAP) by mice. n = 10 in each group. Values are expressed
as mean ± S.E. Data were analyzed by Student t-test.
a = p < 0.05 significant different from vehicle-treated
control group. Values mentioned are doses in mg/kg.
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open area of the maze, (c) number of head dips from closed
area of the maze and (d) number of stretched attend pos-
tures by animal on the maze. These behaviors can be
experimentally recorded reliably in a similar manner as adopted
and reported by several investigators in anxiety research (Pellow
et al., 1985; Shepherd et al., 1994).
Present data indicate that the standard clinical therapeu-
tic option for anxiety, i.e. diazepam, has produced a clear and
consistent behavioral change in test animals in the I-maze.The
proportion of time spent on the open area (one of the behav-
ioral change recorded in the elevated plus-maze procedure or
Zero maze) was increased by diazepam. A detailed behav-
ioral analysis after administration of diazepam also indicated
the similar significant increases in exploratory head dipping
of animals from open space of the I-maze and decrease in
stretched attend postures from the closed to the open arm.
There is an evidence to support the view that a decrease in
SAP is consistent with reduced anxiety (Blanchard et al., 1990,
1991; Kaesermann, 1986; Shepherd et al., 1992a, 1992b). This
finding is in line with observations with the mouse elevated
plus-maze, in that diazepam increased percent time spent by
mice in open arms. Further, I-maze procedure does not involve
measurement of the number of entries in open or closed arm
of maze, as this parameter is associated with conflicting opin-
ions that it may not reflect a measure of anxiety, but more of
locomotor activity. The dual nature of the design of I maze fa-
cilitates not only detailed behavioral analysis but also served
to clearly indicate anxiogenic or anxiolytic behavior in mice,
because it also facilitates the measurement of stretched attend
postures in addition to percent time spent in arms.
Though, it is a generally accepted requirement to validate
animal models of anxiety with benzodiazepines. But it is equally
needful to search for novel classes of anxiolytics which are free
from the numerous problems associated with chronic benzo-
diazepines. The effect of the 5-HT anxiolyic; ondansetron in
Fig. 18 – Effect of ondansetron on percent time spent (%TO)
by mice in open arm. n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. Values mentioned are doses in mg/kg.
Fig. 19 – Effect of ondansetron on unprotected head dips by
mice. n = 10 in each group. Values are expressed as
mean ± S.E. Data were analyzed by Student t-test. Values
mentioned are doses in mg/kg.
Fig. 20 – Effect of ondansetron on protected head dips by
mice. n = 10 in each group. Values are expressed as
mean ± S.E. Data were analyzed by Student t-test. Values
mentioned are doses in mg/kg.
Fig. 21 – Effect of ondansetron on stretch attend postures
by mice. n = 10 in each group. Values are expressed as
mean ± S.E. Data were analyzed by Student t-test. Values
mentioned are doses in mg/kg.
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the I-maze is important in view of the variable reports in the
literature with this drug. In this category, ondansetron has given
inconsistent results in the past literature including anxiolytic
(Costall et al., 1989; Tomkins et al., 1990) and no effect (File and
Johnston, 1989; Wright et al., 1992). In the present study too,
data failed to indicate any significant effects of ondansetron.
It is understood that an objective of a novel animal model is
the detection of anxiolytics which produce their effects in a
different manner to those of the benzodiazepines, probably
acting via different underlying neurochemical mechanisms.
Therefore, it would be acceptable to record behavioral profile
that is achieved using non-benzodiazepines.
Among anticonvulsants, used in the treatment of anxiety
are carbamazepine, valproate and gabapentin, pregabalin and
tiagabin. Gabapentin has been found to increase GABA content
after its administration (Pollack et al., 1998). It has also been
used to validate elevated plus maze and zero maze, two ef-
fective models of anxiety (Kulkarni et al., 2008). In the present
study too, gabapentin has significantly exerted antianxiety-
like profile as it has significantly increased time spent by mice
in open arm of I-maze as well as increased the unprotected
head dips and significantly decreased the protected head dips
as well as stretch attend postures by mice.
SSRIs have been observed to be most effective for anxiety
treatment (Zohar and Westenberg, 2000). Fluoxetine has also
shown a significant antianxiety-like activity as it signifi-
cantly increased time spent by mice in open arm of I-maze as
well as increased the unprotected head dips and signifi-
cantly stretch attend postures by mice. However, it failed to
produce any significant change in the number of protected head
dips in mice as compared to vehicle-treated control mice.
Observations with caffeine as an anxiogenic agent (Baldwin
et al., 1989), further illustrate the utility of I-maze for de-
tailed behavioral analysis of mice. Results with caffeine on
I-maze indicate the anxiogenic-like activity, as evident by a
Fig. 22 – Effect of caffeine on percent time spent (%TO) by
mice in open arm. n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. a = p < 0.05 significant different from vehicle-treated
control group. Values mentioned are doses in mg/kg.
Fig. 23 – Effect of caffeine on number of unprotected head
dips (uHDIPS) by mice. n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. a = p < 0.05 significant different from vehicle-treated
control group. Values mentioned are doses in mg/kg.
Fig. 24 – Effect of caffeine on number of protected head dips
(pHDIPS) by mice. n = 10 in each group. Values are
expressed as mean ± S.E. Data were analyzed by Student
t-test. a = p < 0.05 significant different from vehicle-treated
control group. Values mentioned are doses in mg/kg.
Fig. 25 – Effect of caffeine on stretch attend postures by
mice. n = 10 in each group. Values are expressed as
mean ± S.E. Data were analyzed by Student t-test.
a = p < 0.05 significant different from vehicle-treated
control group. Values mentioned are doses in mg/kg.
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significant decrease in behaviors, indicative of increase in
anxiety like (a) time spent by mice in open area of the maze
and (b) unprotected head dips; and a significant increase in
behaviors, indicative of anxiety like (a) protected head dips and
(b) stretch attend postures.
In the present study, significant increases in the levels of
plasma nitrate and plasma corticosterone suggest the pos-
sible usefulness of the feasible design of the present maze to
bring the relevant biochemical changes associated with anxiety
behavior in mice.
Finally, resultant observed advantages of “elevated I-maze”
comprise (a) I-maze avoids central platform of plus maze, (b)
in plus maze, observations are based on animal’s preference
for any one arm, which is chosen after its movement from the
arm in which the animal is present in that very time frame.
On the other hand, I-maze offers an ever-ready vision of closed
arms in front of its eye. This ever-ready vision helps animals
to make a quick choice without spending even a single second
of observation period (300 s). Straight vision and choice inher-
ent in I-maze serve to avoid a time lapse spent by animals in
any of the arm and a situation, where animals can volun-
tarily choose or decline a clear visible option, (c) design of
I–maze facilitate expedited exploration of maze because, as the
animal reaches at the end of closed end, it spontaneously turns
back and encounters a much clear and wider view (option) of
open space, present inherently between two closed arms
(choices). This situation presented by I-maze further helps the
animal to clearly make its choice between open or closed arm
without being fascinated or intrigued by longer animal stay in
closed as well as open arms of plus maze. (d) I-maze pro-
vides a visible clue to animals, besides providing a relatively
“frank” open space, if, at all, they are lost in its complex
thoughts, arising out of integral confusion of anxiety disor-
der, as compared to the elevated plus maze or Zero maze, where
other arms are not visible, when an animal is in any one arm
(open or closed). Further, authors opine that I-maze provides
a robust measure of animal’s preference for any of the two en-
vironments because I-maze tests the animal preference in
relatively “frank” options.
5. Conclusion
Preliminary evidence suggests the utility of I-maze to explore
detailed behavior of mice for testing of mice behaviors for
anxiogenic-like as well as anxiolytic-like activity. In conclu-
sion, the results suggest that the design of elevated I maze
facilitates expression of anxiety-like behavior of mice and may
prove to be a reliable model of anxiety.
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Values are expressed as mean ± S.E. Data were analyzed by
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